Predict your next investment

Private Equity
infinity-equity.com

See what CB Insights has to offer

Investments

42

Portfolio Exits

7

Funds

1

Partners & Customers

1

About Infinity Group (China)

Infinity Group focuses on creating mutually beneficial relationships that combine ingenuity in a wide variety of industries with the Chinese business acumen and its fast growing market. Infinity manages and invests in advanced Chinese-Israeli-North American companies seeking to enhance their existing business activities in China. Infinity looks for Chinese operational enterprises that display well established entrepreneurial, sales and production skills, and which are seeking cutting-edge technology and knowhow.

Infinity Group (China) Headquarter Location

Units 2001, 20th Floor Harbour Centre, 25 Harbour Road

Wanchai,

Hong Kong

+852-21869016

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Infinity Group (China) Investments

42 Investments

Infinity Group (China) has made 42 investments. Their latest investment was in Laekna Therapeutics as part of their Series D on May 5, 2022.

CBI Logo

Infinity Group (China) Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/18/2022

Series D

Laekna Therapeutics

$61M

Yes

2

5/12/2022

Private Equity

Youxun Medical

Yes

1

4/8/2022

Series B - III

Renderbus

Yes

1

4/2/2022

Series A

Subscribe to see more

Subscribe to see more

10

3/24/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/18/2022

5/12/2022

4/8/2022

4/2/2022

3/24/2022

Round

Series D

Private Equity

Series B - III

Series A

Series B

Company

Laekna Therapeutics

Youxun Medical

Renderbus

Subscribe to see more

Subscribe to see more

Amount

$61M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

1

10

10

Infinity Group (China) Portfolio Exits

7 Portfolio Exits

Infinity Group (China) has 7 portfolio exits. Their latest portfolio exit was Hinova Pharmaceuticals on April 12, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/12/2022

IPO

$99M

Public

1

3/14/2022

IPO

Subscribe to see more

$99M

Subscribe to see more

10

1/12/2022

IPO

Subscribe to see more

$99M

Subscribe to see more

10

12/16/2016

IPO

Subscribe to see more

$99M

Subscribe to see more

10

5/31/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/12/2022

3/14/2022

1/12/2022

12/16/2016

5/31/2016

Exit

IPO

IPO

IPO

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Infinity Group (China) Fund History

1 Fund History

Infinity Group (China) has 1 fund, including Infinity Neusoft Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/26/2016

Infinity Neusoft Fund

$250M

1

Closing Date

9/26/2016

Fund

Infinity Neusoft Fund

Fund Type

Status

Amount

$250M

Sources

1

Infinity Group (China) Partners & Customers

1 Partners and customers

Infinity Group (China) has 1 strategic partners and customers. Infinity Group (China) recently partnered with Burrill & Company on October 10, 2010.

Date

Type

Business Partner

Country

News Snippet

Sources

10/12/2010

Partner

United States

News - Burrill & Company and Infinity Group Form Joint Venture Focusing on Life Science Opportunities in China - Burrill

The mandate of the joint venture will be to pursue life science investment opportunities in China ; Burrill and Infinity Group will co-invest as equal partners in US dollar and RMB investments .

1

Date

10/12/2010

Type

Partner

Business Partner

Country

United States

News Snippet

News - Burrill & Company and Infinity Group Form Joint Venture Focusing on Life Science Opportunities in China - Burrill

The mandate of the joint venture will be to pursue life science investment opportunities in China ; Burrill and Infinity Group will co-invest as equal partners in US dollar and RMB investments .

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.